227 related articles for article (PubMed ID: 8655713)
1. Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.
Seregard S
J Clin Pathol; 1996 Apr; 49(4):338-42. PubMed ID: 8655713
[TBL] [Abstract][Full Text] [Related]
2. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
3. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival melanosis and melanoma.
Folberg R; McLean IW; Zimmerman LE
Ophthalmology; 1984 Jun; 91(6):673-8. PubMed ID: 6462625
[TBL] [Abstract][Full Text] [Related]
7. In vivo confocal microscopy of pigmented conjunctival tumors.
Messmer EM; Mackert MJ; Zapp DM; Kampik A
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
[TBL] [Abstract][Full Text] [Related]
8. Histological criteria for grading of atypia in melanocytic conjunctival lesions.
Maly A; Epstein D; Meir K; Pe'er J
Pathology; 2008 Dec; 40(7):676-81. PubMed ID: 18985522
[TBL] [Abstract][Full Text] [Related]
9. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
van Ipenburg JA; de Waard NE; Naus NC; Jager MJ; Paridaens D; Verdijk RM
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2950-2957. PubMed ID: 31305861
[TBL] [Abstract][Full Text] [Related]
10. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
Sugiura M; Colby KA; Mihm MC; Zembowicz A
Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
[TBL] [Abstract][Full Text] [Related]
11. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma of the conjunctiva.
Folberg R; McLean IW; Zimmerman LE
Hum Pathol; 1985 Feb; 16(2):136-43. PubMed ID: 3972396
[TBL] [Abstract][Full Text] [Related]
14. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
McDonnell JM; Sun YY; Wagner D
Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
[TBL] [Abstract][Full Text] [Related]
15. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.
Larsen AC; Dahl C; Dahmcke CM; Lade-Keller J; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
Acta Ophthalmol; 2016 Aug; 94(5):463-70. PubMed ID: 27009410
[TBL] [Abstract][Full Text] [Related]
17. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
[TBL] [Abstract][Full Text] [Related]
18. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE; Miller DM; Zegans ME
J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
[TBL] [Abstract][Full Text] [Related]
19. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]